HomeCURX • NASDAQ
add
Curanex Pharmaceuticals Inc
Previous close
$0.51
Day range
$0.49 - $0.54
Year range
$0.26 - $9.18
Market cap
14.50M USD
Avg Volume
8.77M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 786.34K | 1,130.29% |
Net income | -3.07M | -2,140.49% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.97M | 3,240.12% |
Total assets | 11.58M | 2,135.83% |
Total liabilities | 361.04K | 2,377.12% |
Total equity | 11.22M | — |
Shares outstanding | 28.36M | — |
Price to book | 1.28 | — |
Return on assets | -59.34% | — |
Return on capital | -59.66% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -3.07M | -2,140.49% |
Cash from operations | -857.40K | -798.47% |
Cash from investing | — | — |
Cash from financing | 0.00 | — |
Net change in cash | -857.40K | -798.47% |
Free cash flow | 323.78K | 544.21% |
About
Founded
1996
Website
